Mutations in ABCC6 cause pseudoxanthoma elasticum

Abstract

Pseudoxanthoma elasticum (PXE) is a heritable disorder of the connective tissue. PXE patients frequently experience visual field loss and skin lesions, and occasionally cardiovascular complications1,2,3,4. Histopathological findings reveal calcification of the elastic fibres and abnormalities of the collagen fibrils5. Most PXE patients are sporadic, but autosomal recessive and dominant inheritance are also observed6,7. We previously localized the PXE gene to chromosome 16p13.1 (refs 8,9) and constructed a physical map10. Here we describe homozygosity mapping in five PXE families and the detection of deletions or mutations in ABCC6 (formerly MRP6) associated with all genetic forms of PXE in seven patients or families.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Clinical phenotype, segregation and mutation analysis in a large arPXE pedigree (P-12).
Figure 2: Overview of the positional identification of the PXE gene.
Figure 3: RT–PCR of ABCC6 RNA in various tissues.

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. 1

    Yap, E.Y., Gleaton, M.S. & Buettner, H. Visual loss associated with pseudoxanthoma elasticum. Retina 12, 315–319 (1992).

  2. 2

    Christiano, A.M. & Uitto, J. Molecular pathology of the elastic fibers. J. Invest. Dermatol. 103, 53S–57S (1994).

  3. 3

    Mendelsohn, G., Bulkley, B.H. & Hutchins, G.M. Cardiovascular manifestations of pseudoxanthoma elasticum. Arch. Pathol. Lab. Med. 102, 298–302 (1978).

  4. 4

    Lebwohl, M. et al. Abnormalities of connective tissue components in lesional and non-lesional tissue of patients with pseudoxanthoma elasticum. Arch. Dermatol. Res. 285, 121–126 (1993).

  5. 5

    Hausser, I. & Anton-Lamprecht, I. Early preclinical diagnosis of dominant pseudoxanthoma elasticum by specific ultrastructural changes of dermal elastic and collagen tissue in a family at risk. Hum. Genet. 87, 693–700 (1991).

  6. 6

    Christiano, A.M., Lebwohl, M.B., Boyd, C.D. & Uitto, J. Workshop on pseudoxanthoma elasticum: molecular biology and pathology of the elastic fibres. Jefferson Medical College, Philadelphia, Pennsylvania, June 10, 1992. J. Invest. Dermatol. 99, 660–663 (1992).

  7. 7

    Lebwohl, M. et al. Classification of pseudoxanthoma elasticum: report of a consensus conference. J. Am. Acad. Dermatol. 30, 103–107 (1994).

  8. 8

    van Soest, S. et al. A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1. Genome Res. 7, 830–834 (1997).

  9. 9

    Struk, B., Neldner, K.H., Rao, V.S., St Jean, P. & Lindpaintner, K. Mapping of both autosomal recessive and dominant variants of pseudoxanthoma elasticum to chromosome 16p13.1. Hum. Mol. Genet. 6, 1823–1828 (1997).

  10. 10

    Le Saux, O. et al. Pseudoxanthoma elasticum maps to an 820 kb region of the p13.1 region of chromosome 16. Genomics 62, 1–10 (1999).

  11. 11

    Hipfner, D.R., Deeley, R.G. & Cole, S.P. Structural, mechanistic and clinical aspects of MRP1. Biochim. Biophys. Acta 6, 359–376 (1999).

  12. 12

    Kool, M., van der Linden, M., de Haas, M., Baas, F. & Borst, P. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res. 59, 175–182 (1999).

  13. 13

    Allikmets, R., Gerrard, B., Hutchinson, A. & Dean, M. Characterisation of the human ABC superfamily: Isolation and mapping of 21 new genes using the expressed sequence tags database. Hum. Mol. Genet. 10, 1649–1655 (1996).

  14. 14

    Hoogendijk, J.E. et al. De novo mutations in hereditary motor and sensory neuropathy type 1. Lancet 339, 1081–1082 (1992).

  15. 15

    Leeds, P. et al. The product of the yeast UPF1 gene is required for rapid turnover of mRNAs containing a premature translational termination codon. Genes Dev. 5, 2303–2314 (1991).

  16. 16

    Culbertson, M.R. RNA surveillance: unforeseen consequences for gene expression, inherited genetic disorders and cancer. Trends Genet. 15, 74–80 (1999).

  17. 17

    Christiano, A.M., McGrath, J.A., Tan, K.C. & Uitto, J. Glycine substitutions in the triple-helical region of type VII collagen result in a spectrum of dystrophic epidermolysis bullosa phenotypes and patterns of inheritance. Am. J. Hum. Genet. 58, 671–681 (1996).

  18. 18

    Van Ommen, G.J.B. Merging autosomal dominance and recessivity. Am. J. Hum. Genet. 41, 689–691 (1987).

  19. 19

    Van Soest, S., Westerveld, A, de Jong, P.T.V.M., Bleeker-Wagemakers, E.M. & Bergen, A.A.B. Retinitis pigmentosa: defined from a molecular point of view. Surv. Ophthalmol. 43, 321–334 (1999).

  20. 20

    Dietz, H.C. et al. The skipping of constitutive exons in vivo induced by nonsense mutations. Science 259, 680–683 (1993).

  21. 21

    Dietz, H.C. & Kendzior, R.J. Jr Maintenance of an open reading frame as an additional level of scrutiny during splice site selection. Nature Genet. 8, 183–188 (1994).

  22. 22

    Bergen, A.A.B. et al. Detection of a new submicroscopic Norrie disease deletion interval with a novel DNA probe isolated by differential Alu PCR fingerprint cloning. Cytogenet. Cell Genet. 62, 231–235 (1993).

  23. 23

    Dauwerse, J.G. et al. Cloning the breakpoint cluster region of the inv (16) in acute nonlymphocytic leukemia M4 Eo. Hum. Mol. Genet. 2, 1527–1534 (1993).

Download references

Acknowledgements

We thank C. Boyd for sharing unpublished data; R.J. Oostra, R. Hennekam, N.T. Tijmes, P. van den Berg, L. Kornet, J.R.M. Cruysberg and F. Steijlen for examination of patients; F. Cremers, C. de Vries and J. Wijnholds for RNA of different tissues; M. Lettink, M.T. van Meegen and D. Schildknegt for technical assistance; and the PXE families for their support. This study was supported by a ANVtVB-grant to A.A.B.B.

Author information

Correspondence to Arthur A.B. Bergen.

Rights and permissions

Reprints and Permissions

About this article

Further reading